Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 06 Jul 2024 02:50:44 +0200Wed, 26 Jun 2024 16:25:00 +0200Agamree : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5679_en_1.pdfAgamree : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5679_en_1.pdfWed, 26 Jun 2024 16:25:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Agamree, Vamorolone, Date of authorisation: 14/12/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/agamreeHuman medicines European public assessment report (EPAR): Agamree, Vamorolone, Date of authorisation: 14/12/2023, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/agamreeWed, 26 Jun 2024 12:11:00 +0200Human medicine